Overview

TDT 067 Onychomycosis Study

Status:
Unknown status

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to establish the efficacy, clinical benefits, and safety of treatment with TDT 067 for clinically diagnosed distal subungual onychomycosis of the toenails caused by dermatophytes confirmed by positive mycology.

Phase:

Phase 3

Details

Lead Sponsor:

Celtic Pharma Development Services

Collaborator:

PPD

Treatments:

Terbinafine